TRAW Updates Guidance
Traws Pharma provides updated guidance on influenza prophylaxis program with resubmission of data package to MHRA expected in 3Q 2026
TRAW - Traws Pharma Provides Updated Guidance on Influenza Prophylaxis ProgramResubmission of updated data package to MHRA, expected in 3Q 2026, to enable Phase 2a human influenza Challenge study to proceed